James J. Ferguson III will resign as Chief Medical Officer of Cadrenal Therapeutics, Inc. effective July 31, 2026. The company is searching for a replacement and negotiating separation terms. Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic solutions for patients with complex medical needs.
